| ID: |
TARP-082 |
| Title: |
Canada – Patent Protection of Pharmaceutical Products |
| Source: |
http://www.wto.org, http://www.dfait-maeci.gc.ca/tna-nac/dispute-en.asp#panel |
| Parties: |
Complaint: European Communities; Respondent: Canada |
| Dispute Resolution Organ: |
WTO Panel |
| Year: |
2000 |
| Pages: |
0 |
| Author(s): |
|
| Keywords: |
Canada, intellectual property, patent protection, pharmaceutical products, trade, TRIPS |
| Abstract: |
The Panel ruled that Section 55.2(2), the so-called stockpiling provision violates Article 28.1 of the TRIPS Agreement, which provides: 1. A patent shall confer on its owner the following exclusive rights: (a) Where the subject-matter of a patent is a product, to prevent third parties not having the owner’s consent from the acts of making, using, offering for sale, selling, or importing for these purposes that product;” |
| Secured: |
False |
| Download Article: |
7428d.pdf |
Keywords: Canada, intellectual property, patent protection, pharmaceutical products, trade, TRIPS
